Allergy Diagnostics Market | Insights and In Depth Analysis of Industry Segments and Key Players

According to the new market research report “Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) – Global Forecast” published by MarketsandMarkets™.

Revenue Growth Opportunities and Growth Drivers?

The Allergy Diagnostics Market is projected to reach USD 5.74 Billion, at a CAGR of 10.5%

Growth Boosting Factors:

# High Incidence and Large Economic Burden of Allergic Diseases
# Rising Environmental Pollution Levels
# Increasing Healthcare Expenditure
# Increasing Access for Allergy Diagnosis Medical Insurance in the US

Growth Opportunity: Growing adoption of automation for quicker turnaround times;

Turnaround time (TAT) is an important factor in laboratory services and is often used as a key indicator of laboratory performance. Fully automated immunoassay systems are popular as they improve the TAT of laboratories and reduce labor costs. Semi-automated instruments are also preferred as they are less expensive; however, these systems increase the TAT. To meet the requirement of increased on-board testing capacity, advanced allergy diagnostic tests have been introduced in the market. Also, the market is witnessing greater adoption of automation for quicker TAT.

Ask For Free Research Sample Pages: www.marketsandmarkets.com/requestsampleNew.asp?id=232871701

Leading Key Players in the Worldwide Industry:
The key players operating in the allergy diagnostics market include Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd. (Japan), bioMérieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US).

Geographical Regions Mapped in Report:

The allergy diagnostics market is segmented into four major regions, namely, North America, Europe, Asia, and the Rest of the World. North America accounted for the largest share of this market owing to the high healthcare expenditure and the strong presence of key market players in the region. These factors, coupled with the rising prevalence of different types of allergies, have resulted in the wide availability and adoption of various allergy diagnostic products and services in the US and Canada.

Ask For Free PDF Brochure: 
www.marketsandmarkets.com/pdfdownloadNew.asp?id=232871701

Market Segmentation in Detailed:

Based on product & service, the allergy diagnostics market is segmented into assay kits, instruments, and services. Assay kits form the largest and the fastest-growing segment in this market majorly due to the wide availability, large consumption, and the need for the repeat purchase of these kits in allergy testing. Although the cost of instruments is significantly higher than that of assay kits, they account for a lower share of the market owing to their long lifespan (the lifespan of a single instrument is 5 to 10 years) and the limited need for repeat installations. Also, there is a secondary market for used instruments, which are majorly procured by smaller healthcare organizations that cannot afford new instruments.

Based on the allergen, the allergy diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. The inhaled allergens segment is expected to witness the highest growth during the forecast period owing to the increasing environmental pollution levels across the globe.

Leave a Reply

Your email address will not be published. Required fields are marked *